Contributors |
|
xi | |
Acknowledgments |
|
xvii | |
I Overview Of Obesity And Population Studies |
|
|
1 Sleep, Abdominal Obesity, and Metabolic Syndrome |
|
|
|
|
|
|
3 | (1) |
|
Descriptive Epidemiology of Sleep, Obesity, and Cardiometabolic Diseases |
|
|
4 | (7) |
|
|
11 | (2) |
|
|
13 | (1) |
|
|
14 | (5) |
|
2 The New Anthropometrics and Abdominal Obesity: A Body Shape Index, Hip Index, and Anthropometric Risk Index |
|
|
|
|
|
|
19 | (1) |
|
Basic Anthropometrics and Abdominal Obesity |
|
|
20 | (1) |
|
|
21 | (2) |
|
|
23 | (1) |
|
|
24 | (1) |
|
|
24 | (1) |
|
|
24 | (5) |
|
3 Comparing Measures of Obesity: Waist Circumference, Waist-Hip, and Waist-Height Ratios |
|
|
|
Alaa Youssef Ahmed Ahmed Baioumi |
|
|
|
29 | (1) |
|
Obesity and the Pattern of Fat Distribution Is a Central Mechanism in the Development of Obesity Comorbidities |
|
|
30 | (1) |
|
Metabolic Syndrome Definition and Relation to Fat Accumulation |
|
|
31 | (1) |
|
Is There a Healthy Obese Phenotype? |
|
|
32 | (1) |
|
Clinical Measures of Adiposity and Fat Distribution |
|
|
32 | (1) |
|
|
32 | (1) |
|
|
33 | (1) |
|
|
34 | (1) |
|
|
35 | (1) |
|
Direct Measurement of Body Fat Distribution |
|
|
35 | (2) |
|
|
37 | (3) |
|
|
40 | (1) |
|
4 Abdominal Obesity and the Interaction Between Adipocytes and Osteoblasts |
|
|
|
|
|
|
|
|
|
41 | (1) |
|
Visceral Adipose Tissue and Adipokine Action on Bone Health |
|
|
42 | (4) |
|
The Common Origin of Adipocytes and Osteoblasts |
|
|
46 | (1) |
|
|
47 | (1) |
|
|
47 | (35) |
|
|
82 | (1) |
|
Abdominal Obesity in Children |
|
|
82 | (9) |
|
|
91 | (1) |
|
|
91 | |
|
5 Pharmacologic Agents Chapter for Abdominal Obesity |
|
|
|
|
|
51 | (1) |
|
History of Pharmacologic Agents for Obesity |
|
|
52 | (1) |
|
Current Pharmacologic Agents for the Treatment of Obesity |
|
|
53 | (1) |
|
|
54 | (1) |
|
|
55 | (1) |
|
|
56 | (2) |
|
Phentermine/Topiramate Extended Release |
|
|
58 | (1) |
|
Naltrexone/Bupropion Sustained Release |
|
|
59 | (2) |
|
|
61 | (1) |
|
Place in Therapy for Antiobesity Prescription Drugs |
|
|
62 | (2) |
|
|
64 | (1) |
|
|
64 | (3) |
|
6 Sleeve Gastrectomy for Morbid Obesity: Technique and Outcomes |
|
|
|
|
|
|
|
|
67 | (1) |
|
|
68 | (1) |
|
|
68 | (1) |
|
|
69 | (1) |
|
|
70 | (1) |
|
|
70 | (3) |
|
7 Waist Circumference: Measures and Applications to Obesity |
|
|
|
|
|
Andres Ricardo Buendia Jaime |
|
|
|
|
|
73 | (1) |
|
|
74 | (1) |
|
|
75 | (2) |
|
|
77 | (1) |
|
|
77 | (5) |
|
8 Abdominal Obesity in Children: The Role of Physical Activity, Sedentary Behavior, and Sleep Time |
|
|
|
Marcus Vinicius Nascimento-Ferreira |
|
|
|
Augusto Cesar Ferreira De Moraes |
|
|
|
Heraclito Barbosa Carvalho |
|
|
|
82 | (1) |
|
Abdominal Obesity in Children |
|
|
82 | (9) |
|
|
91 | (1) |
|
|
91 | (5) |
|
9 The Concept of a Web-Based Calculator for Supporting Waist Circumference Interpretation Among Pediatric Patients |
|
|
|
|
|
|
Waist Circumference-Based Indicators in Pediatric Subjects: Importance in Diagnostics and Monitoring of Obesity Complications |
|
|
96 | (1) |
|
Internet-Based Technology Supporting the Interpretation of WC and Body Composition in Pediatric Subjects: Examples of Solutions |
|
|
97 | (1) |
|
Web-Based Calculator for Supporting WC Interpretation Among Pediatric Patients: Own Concepts |
|
|
98 | (3) |
|
|
101 | (2) |
|
|
103 | (4) |
|
10 Remission of Metabolic Syndrome After Sleeve Gastrectomy |
|
|
|
|
|
|
107 | (1) |
|
Effect of SG on Type 2 Diabetes Mellitus |
|
|
108 | (1) |
|
Effect of SG on Lipid Profile |
|
|
109 | (1) |
|
Effect of SG on Hypertension |
|
|
109 | (1) |
|
|
110 | (1) |
|
|
110 | (1) |
|
|
111 | (7) |
|
|
|
|
Jean Francisco Vettorazzi |
|
|
Renato Chaves Souto Branco |
|
|
Everardo Magalhaes Carneiro |
|
|
|
118 | (5) |
|
12 The Role of Physical Activity in Adult Obesity |
|
|
|
|
|
|
|
|
123 | (1) |
|
Defining PA and Physical Fitness |
|
|
124 | (1) |
|
Effects of PA on Obese and Obese Diabetic Population |
|
|
124 | (3) |
|
|
127 | (5) |
II Mechanisms Of Obesity |
|
|
13 Fibroblast Growth Factor 21 as a Regulator of Energy Metabolism in the Liver and Adipose Tissue |
|
|
|
|
|
|
132 | (1) |
|
Structure, Expression Sites, and Receptor Binding of FGF21 |
|
|
132 | (1) |
|
Paracrine/Autocrine, Endocrine, and Pharmacological Roles of FGF21 |
|
|
133 | (1) |
|
Production and Regulation of FGF21 Expression |
|
|
133 | (3) |
|
Physiological Role of FGF21 |
|
|
136 | (5) |
|
The Role of FGF21 in Human Metabolic Diseases |
|
|
141 | (2) |
|
|
143 | (4) |
|
|
147 | (6) |
|
14 Genetics of Central Obesity and Body Fat |
|
|
|
|
|
|
153 | (1) |
|
|
154 | (1) |
|
|
155 | (1) |
|
Genome-Wide Linkage Study |
|
|
155 | (1) |
|
Candidate-Gene Association Study |
|
|
156 | (1) |
|
Genome-Wide Association Study |
|
|
157 | (7) |
|
Gene-Environment Interactions |
|
|
164 | (2) |
|
|
166 | (1) |
|
|
167 | (1) |
|
|
167 | (1) |
|
|
168 | (7) |
|
15 Stress-Induced Eating Dampens Physiological and Behavioral Stress Responses |
|
|
|
|
Lauren Tiongco-Hofschneider |
|
|
|
|
175 | (2) |
|
Glucocorticoids and Insulin Promote Stress-Induced Eating |
|
|
177 | (1) |
|
Glucocorticoids and Insulin Promote Visceral Fat Accumulation |
|
|
177 | (1) |
|
Stress-Induced Eating Dampens Physiological and Behavioral Stress Responses |
|
|
178 | (2) |
|
Reinforcement of Stress-Induced Eating Via Affective Responses, the Reward System, and Enhanced Memory |
|
|
180 | (1) |
|
Role of Glucocorticoids and Visceral Fat in Dampening Stress Responses |
|
|
181 | (2) |
|
Conclusion and Future Directions |
|
|
183 | (1) |
|
|
184 | (6) |
|
16 An Emerging Role of the Angiotensin Receptor Binding Protein ATRAP as a Possible Novel Player in the Pathophysiology of Visceral Obesity and Metabolic Disorders |
|
|
|
|
|
|
|
|
|
|
Renin-Angiotensin System and Visceral Obesity |
|
|
190 | (2) |
|
|
192 | (1) |
|
The Function of ATRAP in Cardiovascular Cells and Tissues |
|
|
193 | (2) |
|
Decreased ATRAP Expression in Adipose Tissue in Metabolic Disorders |
|
|
195 | (2) |
|
ATRAP Deficiency Exacerbates Metabolic Disorders |
|
|
197 | (2) |
|
ATRAP Enhancement Improves Metabolic Disorders |
|
|
199 | (6) |
|
|
205 | (1) |
|
|
206 | (5) |
|
17 Ethnicity and Cut-Off Values in Obesity |
|
|
|
Ejiroghene Martha Umuerri |
|
|
|
211 | (1) |
|
Ethnicity and Perception of Obesity |
|
|
212 | (1) |
|
Definition and Measurement of Obesity: |
|
|
|
|
212 | (2) |
|
|
214 | (1) |
|
Ethnic-Specific BMI Cut-Off Values |
|
|
215 | (2) |
|
Cut-off Values for Abdominal Obesity |
|
|
217 | (1) |
|
|
217 | (1) |
|
|
217 | (1) |
|
|
218 | (1) |
|
Ethnicity and Central Obesity Cut-Off Values |
|
|
218 | (2) |
|
|
220 | (8) |
III Role Of Dietary Supplements In Obesity |
|
|
18 Regulation of the Energy Balance |
|
|
|
Eduardo Emanuel Satiro Vieira |
|
|
|
Emidio Marques De Matos-Neto |
|
|
Francisco Leonardo Torres-Leal |
|
|
|
228 | (1) |
|
Concepts of the Energy Homeostasis |
|
|
228 | (1) |
|
|
229 | (1) |
|
Central Hypothalamic Regulation of Energy Balance |
|
|
230 | (3) |
|
Regulation of Short-Term Food Intake by Peripheral Signals |
|
|
233 | (1) |
|
Regulation of Long-Term Food Intake by Peripheral Signals |
|
|
234 | (1) |
|
Effects of Diet on Adaptative Thermogenesis |
|
|
235 | (1) |
|
Locomotor Activity and Energy Balance |
|
|
236 | (2) |
|
|
238 | (1) |
|
|
239 | (6) |
|
19 Using Psyllium to Prevent and Treat Obesity Comorbidities |
|
|
|
|
|
|
|
|
245 | (1) |
|
|
246 | (1) |
|
Body Composition and Appetite |
|
|
247 | (2) |
|
Blood Sugar Levels and Insulin Regulation |
|
|
249 | (1) |
|
|
250 | (3) |
|
|
253 | (2) |
|
|
255 | (1) |
|
|
255 | (1) |
|
|
256 | (5) |
|
20 Dairy Whey Proteins and Obesity |
|
|
|
|
|
|
|
|
261 | (2) |
|
|
263 | (3) |
|
Glucose and Insulin Concentrations |
|
|
266 | (2) |
|
|
268 | (1) |
|
|
269 | (2) |
|
|
271 | (1) |
|
|
272 | (1) |
|
|
273 | (1) |
|
|
274 | (1) |
|
|
274 | (7) |
IV Foods And Macronutrients In Obesity |
|
|
21 The Mediterranean Diet: What It Is and Its Effect on Abdominal Obesity |
|
|
|
|
|
|
Defining Abdominal Obesity |
|
|
281 | (1) |
|
Body Composition and Abdominal Obesity |
|
|
282 | (1) |
|
The Concept of the Mediterranean Diet |
|
|
283 | (1) |
|
The New Model of Mediterranean Diet |
|
|
284 | (5) |
|
Abdominal Obesity and the Mediterranean Diet in Childhood |
|
|
289 | (1) |
|
Evaluating MD Adherence in Children |
|
|
290 | (2) |
|
Obesity and Abdominal Fat and Mediterranean Diet in Adulthood |
|
|
292 | (4) |
|
|
296 | (1) |
|
|
296 | (5) |
|
22 International Aspects: Abdominal Obesity in Greece |
|
|
|
Maria G. Grammatikopoulou |
|
|
|
|
|
301 | (1) |
|
Historical Perspective and Epigenetic Exposure Timeline |
|
|
302 | (2) |
|
|
304 | (1) |
|
Prevalence of AO in Greece |
|
|
304 | (6) |
|
Familiar Environment and AO Among Greeks |
|
|
310 | (1) |
|
Prenatal Exposure and Epigenetics of AO in Greece |
|
|
310 | (1) |
|
Dietary Pattern and AO in Greece |
|
|
311 | (1) |
|
Physical Activity and AO Among Greeks |
|
|
312 | (1) |
|
Overview and Implications |
|
|
312 | (1) |
|
|
313 | (4) |
|
23 Artificial Sweeteners: Implications for Weight Loss in Obesity |
|
|
|
|
|
|
|
317 | (1) |
|
AS Role in Obesity Management and Comorbidities |
|
|
318 | (7) |
|
Diabetes and Other Conditions Related to Obesity |
|
|
325 | (1) |
|
|
325 | (3) |
|
|
328 | (1) |
|
24 Coffee Intake and obesity |
|
|
|
|
|
|
|
Obesity, Coffee Consumption, and Its Compounds |
|
|
329 | (1) |
|
Coffee and Reduction of Obesity Risk: A Vision From Epidemiological Studies |
|
|
330 | (3) |
|
Coffee and Its Components |
|
|
333 | (2) |
|
Coffee and the Mechanisms That Underlie the Protective Effects Against Obesity |
|
|
335 | (9) |
|
Potential Adverse Effects of Coffee |
|
|
344 | (2) |
|
|
346 | (1) |
|
|
346 | (9) |
V Micronutrients And Dietary Components In Obesity |
|
|
25 Conjugated Linoleic Acid in Human Health: Effects on Weight Control |
|
|
|
|
|
|
355 | (1) |
|
Discovery and Origins of CLA |
|
|
356 | (1) |
|
Antiobeisty Effects of CLA |
|
|
357 | (11) |
|
Other Health Benefits of CLA |
|
|
368 | (4) |
|
|
372 | (1) |
|
|
372 | (11) |
|
26 Serum Magnesium and Abdominal Obesity and Its Consequences |
|
|
|
|
|
Katarzyna Wilemska-Kucharzewska |
|
|
|
|
|
383 | (1) |
|
Magnesium Deficiency and Its Health-Associated Consequences |
|
|
384 | (2) |
|
|
386 | (1) |
|
Mechanism Magnesium Deficiency in Obesity |
|
|
387 | (1) |
|
Magnesium and Abdominal Obesity |
|
|
388 | (1) |
|
|
389 | (1) |
|
|
390 | (3) |
|
27 Integrative Health and Medicine: Dietary Supplements and Modalities for the Treatment of Obesity |
|
|
|
|
|
393 | (1) |
|
|
394 | (1) |
|
|
395 | (1) |
|
IHM and Scientific Evidence |
|
|
395 | (1) |
|
IHM Evidence Outside of the Biologically Based Domain |
|
|
396 | (2) |
|
Biologically Based Systems |
|
|
398 | (1) |
|
|
398 | (2) |
|
|
400 | (2) |
|
|
402 | (1) |
|
|
403 | (2) |
|
|
405 | (1) |
|
|
405 | (4) |
|
28 Anthocyanins: What They Are and How They Relate to Obesity Prevention |
|
|
|
|
|
|
|
409 | (2) |
|
How Anthocyanins Relate to Obesity |
|
|
|
|
411 | (14) |
|
Conclusions and Future Research Perspectives |
|
|
425 | (1) |
|
|
425 | (6) |
|
29 The Positive Effects of Olive Oil Toward Lipotoxicity and Obesity |
|
|
|
|
|
431 | (1) |
|
|
432 | (1) |
|
What Makes Olive Oil So Advantageous Toward Health? |
|
|
433 | (1) |
|
The Benefits of Olive Oil versus Coconut Oil and Others |
|
|
433 | (1) |
|
Conclusion: The Positive Effects of Olive Oil Toward Lipotoxicity and Obesity |
|
|
434 | (1) |
|
|
434 | (3) |
|
30 Effects of Diet-Induced Early-Stage Obesity on a Low-Testosterone Gottingen Minipig |
|
|
|
I. Diaz-Guemes Martin-Portugues |
|
|
|
|
|
|
|
|
437 | (2) |
|
|
439 | (2) |
|
|
441 | (3) |
|
|
444 | (3) |
|
|
447 | (1) |
|
|
447 | (1) |
|
|
447 | (2) |
|
31 The Effects of Fiber on Visceral Fat |
|
|
|
|
|
449 | (1) |
|
|
450 | (1) |
|
The Epidemiology of Abdominal Obesity |
|
|
451 | (2) |
|
Brief Research History and Physiochemistry of Fiber |
|
|
453 | (1) |
|
Dietary Fiber Consumption |
|
|
454 | (1) |
|
Benefits of Fiber on General Health |
|
|
454 | (1) |
|
Relationship Between Fiber and Visceral Fat |
|
|
455 | (1) |
|
|
456 | (1) |
|
|
456 | (1) |
|
|
456 | (3) |
|
32 Carotenoids as a Nutraceutical Therapy for Visceral Obesity |
|
|
|
|
|
|
459 | (2) |
|
|
461 | (11) |
|
|
472 | (1) |
|
|
472 | (5) |
|
|
477 | (3) |
|
33 Laparoscopic Adjustable Gastric Banding (LAGB) as a Bariatric Procedure |
|
|
|
|
|
|
|
|
|
480 | (1) |
|
|
480 | (2) |
|
|
482 | (1) |
|
Results and Weight Loss Outcomes |
|
|
482 | (1) |
|
|
483 | (2) |
|
Reoperation and Conversions |
|
|
485 | (1) |
|
|
486 | (1) |
|
|
487 | (1) |
|
|
487 | (1) |
|
|
487 | (1) |
|
|
487 | (2) |
|
|
489 | (2) |
Index |
|
491 | |